Molecular Recognition and Determination of Interleukins 1β, 6, 12, and 17 in Whole Blood from Diabetic Patients

References

• Alecu, M., L. Geleriu, G. Coman, and L. Galatescu. 1998. The interleukin-1, interleukin 2, interleukin-6 and tumor necrosis factor alpha serological levels in localized and systemic sclerosis. Romanian Journal of Internal Medicine 36:3–4.
   PubMedGoogle Scholar
• Alnek, K., K. Kisand, K. Heilman, A. Peet, K. Varik, and R. Uibo. 2015. Increased blood levels of growth factors proinflammatory cytokines, and Th 17 cytokines in patients with newly diagnosed type 1 diabetes. PLoS One 10 (12):e0142976–16. doi:10.1371/journal.pone.0142976.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2004. Diagnosis and classification of diabetes mellitus. Diabetes Care 27 (supl.1):S5–S10.
   PubMedGoogle Scholar
• Bayley, H., and P. S. Cremer. 2001. Stochastic sensors inspired by biology. Nature 413 (6852):226–30. doi:10.1038/35093038.
   PubMed Web of Science ®Google Scholar
• Butler, A. E., J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler. 2003. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (1):102–10. doi:10.2337/diabetes.52.1.102.
   PubMed Web of Science ®Google Scholar
• Chatzigeorgiou, A., V. Harokopos, C. Mylona-Karagianni, E. Tsouvalas, V. Aidinis, and E. Kamper. 2010. The patter of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Annals of Medicine 42 (6):426–38. doi:10.3109/07853890.2010.495951.
   PubMed Web of Science ®Google Scholar
• Delaney, C. A., B. Tyrberg, L. Bouwens, H. Vaghef, B. Hellman, and D. L. Eizirik. 1996. Sensitivity of human pancreatic islets to peroxynitride-induced cell dysfunction and death. FEBS Letters 394 (3):300–6. doi:10.1016/0014-5793(96)00977-5.
   PubMed Web of Science ®Google Scholar
• Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65–70. doi:10.1136/gut.52.1.65.
   PubMed Web of Science ®Google Scholar
• Gugoasa, L. A., R. I. Stefan-van Staden, A. Dima, C. A. Visan, A. Streinu-Cercel, A. Biris, and B. Calenic. 2015. Fast screening of biological fluids for cytokines and adipokines using stochastic sensing. Microelectronic Engineering 148:64–9. doi:10.1016/j.mee.2015.08.007.
   Web of Science ®Google Scholar
• Halliwell, B. 1994. Free radicals, antioxidants and human disease: Curiosity, cause, or consequence?. The Lancet 344 (8924):721–4. doi:10.1016/S0140-6736(94)92211-X.
   PubMed Web of Science ®Google Scholar
• Hope, J. C., L. S. Kwong, G. Entrican, S. Wattegedera, H. M. Vordermeier, P. Sopp, and C. J. Howard. 2002. Development of detection methods for ruminant interleukin (IL)-12. Journal of Immunological Methods 266 (1-2):117–26. doi:10.1016/S0022-1759(02)00113-8.
   PubMed Web of Science ®Google Scholar
• Jager, J.,. T. Gremeaux, M. Cormont, Y. L. Marchand-Brustel, and J. F. Tanti. 2007. Interleukin 1-b-induced insulin resistance in adypocytes through down-regulation of insulin receptor substrate-1 expression. Journal of Endocrinology. 148 (1):241–5. doi:10.1210/en.2006-0692.
   Web of Science ®Google Scholar
• Kern, P. A., S. Ranganathan, C. Li, L. Wood, and G. Ranganathan. 2001. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology-Endocrinology and Metabolism 280 (5):E745–E751. doi:10.1152/ajpendo.2001.280.5.E745.
   PubMed Web of Science ®Google Scholar
• Khan, A., and Z. Ali. 2014. Normal ranges for acute phase reactants (Interleukin-6, tumour necrosis factor-alpha and c-reactive protein) in umbilical cord blood of healthy term neonates at the Mount Hope Women's Hospital, Trinidad . The West Indian Medical Journal 63 (5):465–9. doi:10.7727/wimj.2012.133.
   PubMed Web of Science ®Google Scholar
• Klaus, G. G., M. B. Pepys, K. Kitajama, and B. A. Askonas. 1979. Activation of mouse complementary by different classes of mouse antibody. Immunology 38:687–95.
   PubMed Web of Science ®Google Scholar
• Kurrer, M. O., S. V. Pakala, H. L. Hanson, and J. D. Katz. 1997. β-cell apoptosis in T cell-mediated autoimmune diabetes. Journal of Immunology. 94:213–8. doi:10.1073/pnas.94.1.213.
   Web of Science ®Google Scholar
• Laurence, J. M., R. Contreras, and W. Chen. 2008. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially, ethnically diverse population of pregnant women, 1999-2015. Diabetes Care 31:899–904. doi:10.2337/dc07-2345.
   PubMed Web of Science ®Google Scholar
• Li, T., and M. Yang. 2011. Electrochemical sensor utilizing ferrocene loaded porous polyelectrolyte nanoparticles as label for the detection of protein biomarker IL-6. Sensors and Actuators B: Chemical 158 (1):361–5. doi:10.1016/j.snb.2011.06.035.
   Web of Science ®Google Scholar
• Lo, H.-C., S.-C. Lin, and Y.-M. Wang. 2004. Relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus. Clinical Biochemistry. 37 (8):666–72. doi:10.1016/j.clinbiochem.2004.02.002.
   PubMed Web of Science ®Google Scholar
• Maedler, K., P. Sergeev, F. Ris, J. Oberholzer, H. I. Joller-Jemelka, G. A. Spinas, N. Kaiser, P. A. Halban, and M. Y. Donath. 2002. Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. Journal of Clinical Investigation 110 (6):851–60. doi:10.1172/JCI200215318.
   PubMed Web of Science ®Google Scholar
• Mathis, D., L. Vence, and C. Benoist. 2001. β-cell death during progression to diabetes. Nature 4:792–8. doi:10.1038/414792a.
   Web of Science ®Google Scholar
• Messina, G. A., N. V. Panini, N. A. Martinez, and J. Raba. 2008. Microfluidic immunosensor design for the quantification of interleukin-6 in human serum samples. Analytical Biochemistry. 380 (2):262–7. doi:10.1016/j.ab.2008.05.055.
   PubMed Web of Science ®Google Scholar
• Ojeda, I., M. Moreno-Guzmán, A. González-Cortés, P. Yáñez-Sedeño, and J. M. Pingarrón. 2014. Electrochemical magnetoimmunosensor for the ultrasensitive determination of interleukin-6 in saliva and urine sample using poly-HRP streptavidin conjugates as labels for signal amplification. Analytical and Bioanalytical Chemistry 406 (25):6363–71. doi:10.1007/s00216-014-8055-6.
   PubMed Web of Science ®Google Scholar
• Rabinovitch, A., W. L. Suarez, and R. F. Power. 1992. Combination therapy with an antioxidant and a corticosteroid prevents autoimmune diabetes in nod mice. Life Sciences 51 (25):1937–43. doi:10.1016/0024-3205(92)90110-B.
   PubMed Web of Science ®Google Scholar
• Ryba-Stanislawowska, M., K. Rybarczyk-Kapturska, M. Mysliwiec, and J. Mysliwsca. 2014. Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4+CD25 FOXP3+ regulatory T cells in young patients with type 1 diabetes. Inflammation 37:1513–20. doi:10.1007/s10753-014-9878-1.
   PubMed Web of Science ®Google Scholar
• Sanchez-Tirado, E., C. Salvo, A. Gonzales-Cortes, P. Yanez-Sedeno, F. Langa, and J. M. Pingarron. 2017. Electrochemical immunosensor for simultaneous determination of interleukin-1beta and tumor necrosis factor alpha in serum and saliva using dual screen printed electrodes modified with functionalized double-walled carbon nanotubes. Analytica Chimica Acta. 30:1–8.
   Google Scholar
• Sauter, N. S., F. T. Schulthess, R. Galasso, L. W. Castellani, and K. Maedler. 2008. The antinflammatorycitokyne interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Journal of Endocrinology. 149 (5):2208–18. doi:10.1210/en.2007-1059.
   Web of Science ®Google Scholar
• Stefan, R. I., and S. G. Bairu. 2003. Monocrystalline diamond paste based electrodes and their applications for the determination of Fe(II) in vitamins. Analytical Chemistry 75 (20):5394–8. doi:10.1021/ac026300b.
   PubMed Web of Science ®Google Scholar
• Stefan-van Staden, R. I., R. M. Ilie-Mihai, L. A. Gugoasa, A. Bilasco, C. A. Visan, and A. Streinu-Cercel. 2018. Molecular recognition of IL-8, IL-10, IL-12, and IL-15 in biological fluids using phtalocyanine-based stochastic sensors. Analytical and Bioanalytical Chemistry 410 (29):7723–37. doi:10.1007/s00216-018-1386-y.
   PubMed Web of Science ®Google Scholar
• Stefan-van Staden, R. I., I. Popa-Tudor, C. Ionescu-Tirgoviste, and R. A. Stoica. 2018. Molecular recognition of pyruvic acid and L-lactate in early-diabetic 1-type stage. Journal of the Electrochemical Society 165 (14):B659–B664. doi:10.1149/2.0361814jes.
   Web of Science ®Google Scholar
• Stouthard, J. M. L., R. P. J. Oude Elferink, and H. P. Sauerwein. 1996. Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications. 220 (2):241–5. doi:10.1006/bbrc.1996.0389.
   PubMed Web of Science ®Google Scholar
• Strassman, G., M. Fong, J. S. Kenney, and C. O. Jacob. 1992. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. Journal of Clinical Investigation 89:1681–4. doi:10.1172/JCI115767.
   PubMed Web of Science ®Google Scholar
• Todd, J. A., T. J. Aitman, R. J. Cornall, S. Ghosh, J. R. Hall, C. M. Hearne, A. M. Knight, J. M. Love, M. A. McAleer, J. B. Prins, et al. 1991. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 351 (6327):542–7. doi:10.1038/351542a0.
   PubMed Web of Science ®Google Scholar
• Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately, and L. Adorini. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. The Journal of Experimental Medicine 181 (2):817–21. doi:10.1084/jem.181.2.817.
   PubMed Web of Science ®Google Scholar
• Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. Journal of Immunology. 146 (9):3074–80.
   PubMed Web of Science ®Google Scholar